219 related articles for article (PubMed ID: 9005812)
1. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
[TBL] [Abstract][Full Text] [Related]
2. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
3. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
Brandt W; Stoldt M; Schinke H
J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737
[TBL] [Abstract][Full Text] [Related]
4. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
5. Distinct conformational preferences of three cyclic beta-casomorphin-5 analogs determined using NMR spectroscopy and theoretical analysis.
Carpenter KA; Schiller PW; Schmidt R; Wilkes BC
Int J Pept Protein Res; 1996 Jul; 48(1):102-11. PubMed ID: 8844269
[TBL] [Abstract][Full Text] [Related]
6. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.
Yamazaki T; Mierke DF; Said-Nejad OE; Felder ER; Goodman M
Int J Pept Protein Res; 1992 Feb; 39(2):161-81. PubMed ID: 1517015
[TBL] [Abstract][Full Text] [Related]
7. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
Liu ZP; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
[TBL] [Abstract][Full Text] [Related]
8. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
9. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
[TBL] [Abstract][Full Text] [Related]
10. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
Shenderovich MD; Nikiforovich GV; Golbraikh AA
Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
[TBL] [Abstract][Full Text] [Related]
11. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
[TBL] [Abstract][Full Text] [Related]
12. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
[TBL] [Abstract][Full Text] [Related]
13. Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.
Vogel D; Schmidt R; Hartung K; Demuth HU; Chung NN; Schiller PW
Int J Pept Protein Res; 1996 Dec; 48(6):495-502. PubMed ID: 8985782
[TBL] [Abstract][Full Text] [Related]
14. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
Yamazaki T; Nunami K; Goodman M
Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
16. Backbone modifications in cyclic peptides. Conformational analysis of a cyclic pseudopentapeptide containing a thiomethylene ether amide bond replacement.
Anwer MK; Sherman DB; Spatola AF
Int J Pept Protein Res; 1990 Oct; 36(4):392-9. PubMed ID: 2079394
[TBL] [Abstract][Full Text] [Related]
17. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
Kazmierski WM; Ferguson RD; Knapp RJ; Lui GK; Yamamura HI; Hruby VJ
Int J Pept Protein Res; 1992 May; 39(5):401-14. PubMed ID: 1358847
[TBL] [Abstract][Full Text] [Related]
18. A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.
Brandt W
J Comput Aided Mol Des; 1998 Nov; 12(6):615-21. PubMed ID: 9879509
[TBL] [Abstract][Full Text] [Related]
19. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
20. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
Stroup AN; Rockwell AL; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
